Cargando…
The value of serum alpha-N-acetylgalactosaminidase measurement for the assessment of tumour response to radio- and photodynamic therapy.
Serum activity of alpha-N-acetylgalactosaminidase (NaGalase), the extracellular matrix-degrading enzyme that appears to be produced exclusively by cancer cells, was measured in mice bearing SCCVII tumours (squamous cell carcinoma). The NaGalase levels in these mice increased with time of tumour grow...
Autores principales: | Korbelik, M., Naraparaju, V. R., Yamamoto, N. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150105/ https://www.ncbi.nlm.nih.gov/pubmed/9528849 |
Ejemplares similares
-
Macrophage-directed immunotherapy as adjuvant to photodynamic therapy of cancer.
por: Korbelik, M., et al.
Publicado: (1997) -
Novel endo-α-N-acetylgalactosaminidases with broader substrate specificity
por: Koutsioulis, Dimitris, et al.
Publicado: (2008) -
Ischaemia-reperfusion injury in photodynamic therapy-treated mouse tumours
por: Korbelik, M, et al.
Publicado: (2003) -
Enzymatic Conversion of RBCs by α-N-Acetylgalactosaminidase from Spirosoma linguale
por: Malinski, Thomas J., et al.
Publicado: (2019) -
Photodynamic therapy-generated vaccines: relevance of tumour cell death expression
por: Korbelik, M, et al.
Publicado: (2007)